A 36 year old premenopausal woman with breast cancer received adjuvant Gose
relin (GnRH-agonist) for 2 years. Six month after finishing therapy she got
pregnant and delivered a female child who was suffering from combined hear
t failure from which it died only a few weeks after delivery.